Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics

OBJECTIVE: Despite recent advancements in targeted therapy and immunotherapies, prognosis for metastatic melanoma patients remains extremely poor. Development of resistance to previously effective treatments presents a serious challenge and new approaches for melanoma treatment are urgently needed....

Descripción completa

Detalles Bibliográficos
Autores principales: Grahovac, Jelena, Srdić-Rajić, Tatjana, Francisco Santibañez, Juan, Pavlović, Marijana, Čavić, Milena, Radulović, Siniša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Anti-Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713633/
https://www.ncbi.nlm.nih.gov/pubmed/31516746
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713633/
https://www.ncbi.nlm.nih.gov/pubmed/31516746
http://dx.doi.org/10.20892/j.issn.2095-3941.2018.0375

Ejemplares similares